News
Short Videos on Patient Input into the CADTH Common Drug Review
CADTH recently produced four short videos describing:
why CADTH values patient input
what elements are most useful to reviewers and expert committee members in groups' patient input submissions
how to submit input.
Canadian Drug Expert Committee Public Member, Frank Gavin an...
Technical difficulties resolved for patient input submissions
We’ve had a few technical problems recently with our Common Drug Review patient input online submission system. Thank you for your patience and understanding while we investigated and fixed the problem. We’ve added new safeguards to enable us to closer track submissions into ou...
Wednesday, September 10, 2014, Ottawa — Dr. Brian O’Rourke, President and CEO of CADTH, today announced the appointment of three new core members to the Health Technology Expert Review Panel:
Jenny Basran, MD, FRCPC — Internist Geriatrician and Associate Professor in the Department of Medicine at the University of Saskatchewan
Leslie Anne Ca...
September 3, 2014, Ottawa — Dr. Brian O’Rourke, President and CEO of CADTH, today announced changes to the leadership of the Canadian Drug Expert Committee.
Dr. Lindsay Nicolle has been appointed the new Chair of the committee and Dr. James Silvius has been appointed Vice-Chair. Their appointments are for two and three-year terms respectively a...
June 24, 2014 - The creation of an Advisory Panel on Healthcare Innovation, announced earlier today by federal Health Minister Rona Ambrose, will help ensure all Canadians benefit from health innovation, said Dr. Brian O’Rourke, President and CEO of CADTH, the pan-Canadian health technology assessment agency.
“There are two positive aspects to ...
